CHD-associated enhancers shape human cardiomyocyte lineage commitment

Enhancers orchestrate gene expression programs that drive multicellular development and lineage commitment. Thus, genetic variants at enhancers are thought to contribute to developmental diseases by altering cell fate commitment. However, while many variant-containing enhancers have been identified, studies to endogenously test the impact of these enhancers on lineage commitment have been lacking. We perform a single-cell CRISPRi screen to assess the endogenous roles of 25 enhancers and putative cardiac target genes implicated in genetic studies of congenital heart defects (CHD). We identify 16 enhancers whose repression leads to deficient differentiation of human cardiomyocytes (CMs). A focused CRISPRi validation screen shows that repression of TBX5 enhancers delays the transcriptional switch from mid- to late-stage CM states. Endogenous genetic deletions of two TBX5 enhancers phenocopy epigenetic perturbations. Together, these results identify critical enhancers of cardiac development and suggest that misregulation of these enhancers could contribute to cardiac defects in human patients. HIGHLIGHTS Single-cell enhancer perturbation screens during human cardiomyocyte differentiation. Perturbation of CHD-linked enhancers/genes causes deficient CM differentiation. Repression or knockout of TBX5 enhancers delays transition from mid to late CM states. Deficient differentiation coincides with reduced expression of known cardiac genes.

[1]  Thomas M. Norman,et al.  Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq , 2021, Cell.

[2]  Jacob C. Ulirsch,et al.  Direct characterization of cis-regulatory elements and functional dissection of complex genetic associations using HCR-FlowFISH , 2021, Nature Genetics.

[3]  G. Hon,et al.  FBA: feature barcoding analysis for single cell RNA-Seq , 2021, Bioinform..

[4]  Timothy E. Reddy,et al.  Genome-wide annotation of gene regulatory elements linked to cell fitness , 2021, bioRxiv.

[5]  Jun Zhang,et al.  Generation of a TBX5 homozygous knockout embryonic stem cell line (WAe009-A-45) by CRISPR/Cas9 genome editing. , 2021, Stem cell research.

[6]  Kathleen M. Chen,et al.  Genomic analyses implicate noncoding de novo variants in congenital heart disease , 2020, Nature Genetics.

[7]  K. Chien,et al.  Genome‐wide CRISPR screen identifies ZIC2 as an essential gene that controls the cell fate of early mesodermal precursors to human heart progenitors , 2020, Stem cells.

[8]  Joshua M. Stuart,et al.  Modeling Human TBX5 Haploinsufficiency Predicts Regulatory Networks for Congenital Heart Disease. , 2019, Developmental cell.

[9]  G. Hon,et al.  Global Analysis of Enhancer Targets Reveals Convergent Enhancer-Driven Regulatory Modules , 2019, Cell reports.

[10]  Elie N. Farah,et al.  Transcriptionally Active HERV-H Retrotransposons Demarcate Topologically Associating Domains in Human Pluripotent Stem Cells , 2019, Nature Genetics.

[11]  Neva C. Durand,et al.  Activity-by-Contact model of enhancer-promoter regulation from thousands of CRISPR perturbations , 2019, Nature Genetics.

[12]  R. Maehr,et al.  Single-Cell RNA-Sequencing-Based CRISPRi Screening Resolves Molecular Drivers of Early Human Endoderm Development , 2019, Cell reports.

[13]  Michael S. Fernandopulle,et al.  CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons , 2019, Neuron.

[14]  Jacob M. Schreiber,et al.  A Genome-wide Framework for Mapping Gene Regulation via Cellular Genetic Screens , 2019, Cell.

[15]  Bertrand Z. Yeung,et al.  Cell Hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics , 2018, Genome Biology.

[16]  I. van der Made,et al.  RBM20 Mutations Induce an Arrhythmogenic Dilated Cardiomyopathy Related to Disturbed Calcium Handling , 2018, Circulation.

[17]  Fabian J Theis,et al.  SCANPY: large-scale single-cell gene expression data analysis , 2018, Genome Biology.

[18]  R. Backofen,et al.  Distinct epigenetic programs regulate cardiac myocyte development and disease in the human heart in vivo , 2017, Nature Communications.

[19]  Howard Y. Chang,et al.  Genome-Wide Temporal Profiling of Transcriptome and Open Chromatin of Early Cardiomyocyte Differentiation Derived From hiPSCs and hESCs , 2017, Circulation research.

[20]  A. McKenna,et al.  CRISPR/Cas9-Mediated Scanning for Regulatory Elements Required for HPRT1 Expression via Thousands of Large, Programmed Genomic Deletions. , 2017, American journal of human genetics.

[21]  Deanne M. Taylor,et al.  Genome-Wide Association Studies and Meta-Analyses for Congenital Heart Defects , 2017, Circulation. Cardiovascular genetics.

[22]  G. Hon,et al.  Multiplexed Engineering and Analysis of Combinatorial Enhancer Activity in Single Cells. , 2017, Molecular cell.

[23]  B. Li,et al.  A tiling1deletion based genetic screen for cis-regulatory element identification in mammalian cells , 2017, Nature Methods.

[24]  E. Giannoulatou,et al.  Advances in the Genetics of Congenital Heart Disease: A Clinician's Guide. , 2017, Journal of the American College of Cardiology.

[25]  I. Moskowitz,et al.  TBX5: A Key Regulator of Heart Development. , 2017, Current topics in developmental biology.

[26]  Sharon R Grossman,et al.  Systematic mapping of functional enhancer–promoter connections with CRISPR interference , 2016, Science.

[27]  Jeffrey J. Tabor,et al.  FlowCal: A User-Friendly, Open Source Software Tool for Automatically Converting Flow Cytometry Data from Arbitrary to Calibrated Units. , 2016, ACS synthetic biology.

[28]  A. Riggs,et al.  Mapping Human Pluripotent-to-Cardiomyocyte Differentiation: Methylomes, Transcriptomes, and Exon DNA Methylation “Memories” , 2016, EBioMedicine.

[29]  Timothy E. Reddy,et al.  Highly Specific Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements , 2015, Nature Methods.

[30]  Evan Z. Macosko,et al.  Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets , 2015, Cell.

[31]  A. Shilatifard,et al.  Zic2 is an enhancer-binding factor required for embryonic stem cell specification , 2015, Molecular cell.

[32]  Jennifer A. Mitchell,et al.  A Sox2 distal enhancer cluster regulates embryonic stem cell differentiation potential , 2014, Genes & development.

[33]  A. Dean,et al.  Enhancer function: mechanistic and genome-wide insights come together. , 2014, Molecular cell.

[34]  M. Wegner,et al.  Cardiac outflow tract development relies on the complex function of Sox4 and Sox11 in multiple cell types , 2014, Cellular and Molecular Life Sciences.

[35]  M. Wegner,et al.  Cardiac outflow tract development relies on the complex function of Sox4 and Sox11 in multiple cell types , 2013, Cellular and Molecular Life Sciences.

[36]  N. Turner,et al.  Combined effects of interleukin-1α and transforming growth factor-β1 on modulation of human cardiac fibroblast function. , 2013, Matrix biology : journal of the International Society for Matrix Biology.

[37]  Chulan Kwon,et al.  Fibronectin mediates mesendodermal cell fate decisions , 2013, Development.

[38]  S. Heath,et al.  Genome-wide association study of multiple congenital heart disease phenotypes identifies a susceptibility locus for atrial septal defect at chromosome 4p16 , 2013, Nature Genetics.

[39]  遠山 周吾.  Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes , 2013 .

[40]  M. Nóbrega,et al.  Regulatory variation in a TBX5 enhancer leads to isolated congenital heart disease. , 2012, Human molecular genetics.

[41]  J. Roos‐Hesselink,et al.  Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. , 2011, Journal of the American College of Cardiology.

[42]  A. Mackie,et al.  Birth prevalence of congenital heart disease. , 2009, Epidemiology.

[43]  A. Bradley,et al.  Generation of an inducible and optimized piggyBac transposon system , 2007, Nucleic acids research.

[44]  V. Wagh,et al.  Isolation and Functional Characterization of α-Smooth Muscle Actin Expressing Cardiomyocytes from Embryonic Stem Cells , 2006, Cellular Physiology and Biochemistry.

[45]  A. Moorman,et al.  Expression and regulation of the atrial natriuretic factor encoding gene Nppa during development and disease. , 2005, Cardiovascular research.

[46]  D. Haussler,et al.  Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. , 2005, Genome research.

[47]  J. Hoffman,et al.  The incidence of congenital heart disease. , 2002, Journal of the American College of Cardiology.

[48]  J. Schmitt,et al.  A Murine Model of Holt-Oram Syndrome Defines Roles of the T-Box Transcription Factor Tbx5 in Cardiogenesis and Disease , 2001, Cell.

[49]  J. Seidman,et al.  Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome. , 1999, Developmental biology.

[50]  J. Seidman,et al.  Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. , 1997, Nature genetics.

[51]  David I. Wilson,et al.  Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family , 1997, Nature Genetics.

[52]  S. Oram,et al.  FAMILIAL HEART DISEASE WITH SKELETAL MALFORMATIONS , 1960, British heart journal.